Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LifeStance Health (LFST) Change in Account Payables (2020 - 2025)

Historic Change in Account Payables for LifeStance Health (LFST) over the last 6 years, with Q3 2025 value amounting to $3.1 million.

  • LifeStance Health's Change in Account Payables rose 22152.24% to $3.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.7 million, marking a year-over-year increase of 34177.66%. This contributed to the annual value of $501000.0 for FY2024, which is 10893.84% up from last year.
  • LifeStance Health's Change in Account Payables amounted to $3.1 million in Q3 2025, which was up 22152.24% from -$200000.0 recorded in Q2 2025.
  • In the past 5 years, LifeStance Health's Change in Account Payables ranged from a high of $6.6 million in Q4 2022 and a low of -$5.5 million during Q1 2023
  • Its 5-year average for Change in Account Payables is $804764.7, with a median of -$77000.0 in 2025.
  • As far as peak fluctuations go, LifeStance Health's Change in Account Payables skyrocketed by 34871.38% in 2023, and later tumbled by 259718.31% in 2024.
  • Over the past 5 years, LifeStance Health's Change in Account Payables (Quarter) stood at $5.2 million in 2021, then increased by 25.25% to $6.6 million in 2022, then plummeted by 126.79% to -$1.8 million in 2023, then skyrocketed by 93.23% to -$119000.0 in 2024, then skyrocketed by 2742.86% to $3.1 million in 2025.
  • Its Change in Account Payables stands at $3.1 million for Q3 2025, versus -$200000.0 for Q2 2025 and -$77000.0 for Q1 2025.